Boehringer Ingelheim Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Boehringer Ingelheim careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: October 13, 2018, 8:07 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: October 13, 2018, 8:07 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: October 13, 2018, 8:07 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: October 13, 2018, 8:06 am
Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and co...
Posted: October 13, 2018, 8:06 am

Viewing page 1 of 36|Next Page

  Newsfeed | Subscribe  

INGELHEIM, Germany--(Business Wire)--Boehringer Ingelheim today announced that primary results from two key trials, RE-SPECT ESUS ® and RE-SPECT CVT ®, will be presented at the upcoming World Stroke C...
Posted: October 15, 2018, 12:20 am
HTF MI recently introduced Global Smart Inhalers Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2025. The market Study i...
Posted: October 13, 2018, 5:02 am
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in ad...
Posted: October 12, 2018, 11:18 am
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Novel results based on data from the landmark EMPA-REG OUTCOME® trial were published in the journal Circulation wh...
Posted: October 10, 2018, 3:34 am
Law360 (October 9, 2018, 1:22 PM EDT) -- Boehringer Ingelheim Pharmaceuticals has won its third straight bellwether trial over the alleged bleeding risk of its blood thinner Pradaxa, after a Connectic...
Posted: October 9, 2018, 10:40 am

Viewing page 1 of 3|Next Page